LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 68.37 | 27.76 | 1066 | 6879 | 0.1550 | 0.5820 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 68.37 | 27.76 | 858 | 6879 | 0.1247 | 0.5394 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 68.37 | 27.76 | 1454 | 6879 | 0.2114 | 0.6450 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.08 | 27.76 | 19 | 6849 | 0.0028 | -0.0466 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.08 | 27.76 | 1074 | 6849 | 0.1568 | 0.5841 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.08 | 27.76 | 790 | 6849 | 0.1153 | 0.5240 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.08 | 27.76 | 1462 | 6849 | 0.2134 | 0.6468 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.78 | 27.76 | 19 | 6893 | 0.0028 | -0.0465 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.78 | 27.76 | 1066 | 6893 | 0.1547 | 0.5818 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.78 | 27.76 | 723 | 6893 | 0.1049 | 0.5064 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.78 | 27.76 | 1467 | 6893 | 0.2128 | 0.6465 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.48 | 27.76 | 20 | 6957 | 0.0029 | -0.0403 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.48 | 27.76 | 1043 | 6957 | 0.1499 | 0.5762 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.48 | 27.76 | 815 | 6957 | 0.1171 | 0.5282 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.48 | 27.76 | 1496 | 6957 | 0.2150 | 0.6492 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 75.19 | 27.76 | 19 | 7015 | 0.0027 | -0.0464 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 75.19 | 27.76 | 1062 | 7015 | 0.1514 | 0.5787 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 75.19 | 27.76 | 876 | 7015 | 0.1249 | 0.5411 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 75.19 | 27.76 | 1476 | 7015 | 0.2104 | 0.6452 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.89 | 27.76 | 19 | 7025 | 0.0027 | -0.0464 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.89 | 27.76 | 1060 | 7025 | 0.1509 | 0.5782 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.89 | 27.76 | 745 | 7025 | 0.1061 | 0.5100 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.89 | 27.76 | 1488 | 7025 | 0.2118 | 0.6466 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.60 | 27.76 | 10 | 7045 | 0.0014 | -0.1200 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.60 | 27.76 | 1052 | 7045 | 0.1493 | 0.5763 | MN20160318_Q01 | C21 |